Effect of probiotics intake on constipation in children: an umbrella review

Mingyang Dong1, Yuting Wu1, Mengzhen Zhang2

  • 1Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.

Frontiers in Nutrition
|September 18, 2023
PubMed

Insights

Probiotic intake in children with functional constipation (FC) significantly improves treatment success and bowel movement frequency. These probiotics are safe and do not increase adverse events, offering a promising approach for managing childhood constipation.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Microbiome Research

Background:

  • Functional constipation (FC) is a common pediatric gastrointestinal disorder.
  • Current treatments for FC have varying efficacy and potential side effects.
  • The role of probiotics in managing pediatric constipation requires comprehensive evaluation.

Purpose of the Study:

  • To conduct a comprehensive review of existing evidence on probiotic intake for constipation in children.
  • To evaluate the quality, effectiveness, and potential bias of studies examining probiotics for pediatric constipation.
  • To synthesize findings on treatment success, symptom frequency, and adverse events.

Main Methods:

  • Systematic review and meta-analysis of nine existing systematic reviews and meta-analyses.
  • Included data from 628 articles.
  • Analyzed seven effectiveness indicators and adverse reaction incidence in pediatric FC.

Main Results:

  • Probiotic intake significantly improved treatment success rate and defecation frequency in children with FC.
  • A decreased recurrence rate of constipation was observed with probiotic use.
  • No significant associations were found for probiotic intake with abdominal pain, stool consistency, defecation pain, or fecal incontinence.
  • Probiotics demonstrated good safety with no increased incidence of adverse reactions.

Conclusions:

  • Probiotics are effective in improving key outcomes for children with functional constipation, including treatment success and bowel movement frequency.
  • Probiotic supplementation is safe and well-tolerated in pediatric populations with constipation.
  • Further research may explore specific probiotic strains and their targeted effects on constipation-related symptoms.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
201
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
478
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
245
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
264
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
311
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
242